Clinical Pharmacokinetics of Hydralazine

Medicine and Dentistry

• Hydralazine 100%
• Plasma 26%
• Acetylation 21%
• Clearance 15%
• Drug 15%
• Chemotherapeutic Agent 15%
• First Pass Effect 15%
• Acetylator Phenotype 15%
• Blood 15%
• Metabolite 10%
• Bioavailability 10%
• Individualization 10%
• Pharmacokinetics 10%
• Congestive Heart Failure 10%
• Life 10%
• Hydrazone Derivative 10%
• Assay 10%
• Therapeutic Procedure 10%
• Patient 10%
• Urine 5%
• Diseases 5%
• Measurement 5%
• In Vitro 5%
• Drug Dose Regimen 5%
• Metabolism 5%
• Hypertension 5%
• Intravenous Drug Administration 5%
• Mean Arterial Pressure 5%
• Renal Failure 5%
• Volume of Distribution 5%
• Calcium Oxide 5%
• Pyruvic Acid 5%
• Propranolol 5%
• Aerobic Metabolism 5%
• Concentration Response 5%
• Acid 5%
• Oral Drug Administration 5%
• Phthalazine 5%
• Man 5%
• Aptitude 5%
• Urinary System 5%

Chemistry

• Hydralazine 100%
• Concentration 26%
• Acetylation 21%
• Procedure 21%
• Pharmacokinetics 15%
• Pharmacological Metabolism 15%
• Clearance 15%
• Bioavailability 10%
• Oxidation Reaction 10%
• Metabolite 10%
• Reaction Half Life 10%
• Hydrazone 10%
• Assay 10%
• Dose 10%
• Drug Dosage Parameter 10%
• Metabolic 5%
• Derivatization 5%
• Propranolol 5%
• Vd 5%
• Pyruvic Acid 5%
• Reaction Yield 5%
• Phthalazine 5%
• Group 5%
• Sample 5%
• Intravenous 5%
• Pressure 5%
• Chemical Kinetics Characteristics 5%
• Chemical Reaction Product 5%
• Acid 5%
• Adduct 5%
• Experimental Design 5%
• Methyl 5%
• Food 5%

Pharmacology, Toxicology and Pharmaceutical Science

• Hydralazine 100%
• Drug 15%
• Normal Human 10%
• Bioavailability 10%
• Pharmacokinetics 10%
• Congestive Heart Failure 10%
• Hydrazone Derivative 10%
• Diseases 5%
• Hypertension 5%
• Volume of Distribution 5%
• Kidney Failure 5%
• Clinical Pharmacokinetics 5%
• Propranolol 5%
• Pyruvic Acid 5%
• First Pass Effect 5%
• Phthalazine 5%
• Acid 5%
• Elimination 5%
• Calcium Oxide 5%